Charming Medical Ltd
Charming Medical is a Hong Kong-based provider of TCM-inspired wellness and beauty services and products for women, as well as TCM-inspired therapies tailored to men. It operates through Hong Kong subsidiaries and provides services at three wellness centers. Its offerings include women’s wellness, prenatal and postpartum care, beauty treatments, head and eye care, and therapies such as womb-warming, prenatal massage and Indonesian traditional abdominal binding. Under the Beauty Lab brand, it sells products including herbal uterine care patches, probiotic intimate wash, Yin nourishing pills and beauty products. Charming Medical makes money by providing services and selling products, and through Beauty Lab franchises. Franchise-related income comes mainly from initial franchise fees, royalties and promotional fees, brand management fees, and training and administration fees. It also offers technical and dietary therapy training and consultancy to beauty salons, massage centers and similar institutions.
No SEC Form 4 filings for $MCTA in the last 30 days.
See all $MCTA insider activity →Charming Medical (MCTA) received a delisting notice from Nasdaq after a SEC trading suspension due to potential manipulation via social media. The company has until today to appeal. Nasdaq cited Listing Rule IM-5101-4, allowing delisting based on third-party misconduct. Trading will halt Monday if no appeal is filed. The company denies wrongdoing and says operations remain unaffected.
Nasdaq notified Charming Medical (MCTA) of anticipated delisting by November 9, 2026, unless the company appeals. The decision follows standard exchange procedures.
NEW YORK, Nov. 26, 2025 ( GLOBE NEWSWIRE ) -- The Nasdaq Stock Market® ( Nasdaq: NDAQ ) announced that trading is halted in Charming Medical Limited ( Nasdaq: MCTA ) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading ...
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning MCTA (Charming Medical Ltd). Coverage has skewed bearish: 0 bullish, 0 neutral, and 3 bearish.
Recent MCTA coverage spans corporate actions and financial news.
Shares likely to drop sharply as delisting removes Nasdaq listing and limits liquidity.
Potential removal from Nasdaq could pressure the stock lower and limit liquidity.
Trading in Charming Medical Limited (MCTA) is currently halted due to regulatory requests for additional information. This halt introduces uncertainty regarding the company's immediate prospects.
AlphAI scores every news story that mentions MCTA with an AI model for sentiment and relevance, and aggregates insider trades from Charming Medical Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Charming Medical (MCTA) received a delisting notice from Nasdaq after a SEC trading suspension due to potential manipulation via social media. The company has until today to appeal. Nasdaq cited Listing Rule IM-5101-4, allowing delisting based on third-party misconduct. Trading will halt Monday if no appeal is filed. The company denies wrongdoing and says operations remain unaffected.
Nasdaq notified Charming Medical (MCTA) of anticipated delisting by November 9, 2026, unless the company appeals. The decision follows standard exchange procedures.
NEW YORK, Nov. 26, 2025 ( GLOBE NEWSWIRE ) -- The Nasdaq Stock Market® ( Nasdaq: NDAQ ) announced that trading is halted in Charming Medical Limited ( Nasdaq: MCTA ) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading ...
